Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 957034-87-6 | MDL No. : | MFCD09475844 |
Formula : | C11H16BNO4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PTSWGJSCDHDBRA-UHFFFAOYSA-N |
M.W : | 269.13 | Pubchem ID : | 44118555 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.45 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 73.29 |
TPSA : | 86.22 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.36 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.82 |
Log Po/w (WLOGP) : | 0.24 |
Log Po/w (MLOGP) : | -0.19 |
Log Po/w (SILICOS-IT) : | -1.28 |
Consensus Log Po/w : | -0.08 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.07 |
Solubility : | 2.27 mg/ml ; 0.00844 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.21 |
Solubility : | 1.65 mg/ml ; 0.00613 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.94 |
Solubility : | 3.1 mg/ml ; 0.0115 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.97
[ 486422-59-7 ]
4-(N,N-Dimethylsulfamoyl)phenylboronic acid
Similarity: 0.82
[ 486422-68-8 ]
4-(Morpholinosulfonyl)phenylboronic acid
Similarity: 0.81
[ 150691-04-6 ]
(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
Similarity: 0.75
[ 613660-87-0 ]
(4-Aminosulfonylphenyl)boronic acid
Similarity: 0.68
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.97
[ 486422-59-7 ]
4-(N,N-Dimethylsulfamoyl)phenylboronic acid
Similarity: 0.82
[ 486422-68-8 ]
4-(Morpholinosulfonyl)phenylboronic acid
Similarity: 0.81
[ 150691-04-6 ]
(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
Similarity: 0.75
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.97
[ 486422-59-7 ]
4-(N,N-Dimethylsulfamoyl)phenylboronic acid
Similarity: 0.82
[ 486422-68-8 ]
4-(Morpholinosulfonyl)phenylboronic acid
Similarity: 0.81
[ 150691-04-6 ]
(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
Similarity: 0.75
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.97
[ 486422-68-8 ]
4-(Morpholinosulfonyl)phenylboronic acid
Similarity: 0.81
[ 436095-30-6 ]
1-[(2-Aminophenyl)sulfonyl]piperidine
Similarity: 0.70
[ 147636-36-0 ]
1-Tosylpiperidine-4-carboxylic acid
Similarity: 0.67
[ 122080-99-3 ]
3-Tosyl-3-azabicyclo[3.2.0]heptan-6-one
Similarity: 0.66
[ 436095-30-6 ]
1-[(2-Aminophenyl)sulfonyl]piperidine
Similarity: 0.70
[ 147636-36-0 ]
1-Tosylpiperidine-4-carboxylic acid
Similarity: 0.67
[ 7311-93-5 ]
3-(Piperidin-1-ylsulfonyl)benzoic acid
Similarity: 0.65
[ 1428329-80-9 ]
1-(Methylsulfonyl)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine
Similarity: 0.58
[ 1353958-73-2 ]
1-(Pyridin-2-ylsulfonyl)piperidin-4-amine hydrochloride
Similarity: 0.52